WOOJUNG BIO Inc Total Liabilities

Latest as of June 2026: ₩76.72 Billion KRW ≈ $51.99 Million USD

WOOJUNG BIO Inc total liabilities. Based on the latest financial reports, WOOJUNG BIO Inc (215380) has total liabilities worth ₩76.72 Billion KRW (≈ $51.99 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 215380 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of WOOJUNG BIO Inc (2016–2025)

Total liabilities of WOOJUNG BIO Inc from 2016 to 2025. This chart illustrates how WOOJUNG BIO Inc's total liabilities have evolved over time, based on quarterly financial data. Explore WOOJUNG BIO Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.

WOOJUNG BIO Inc Competitors by Total Liabilities

The table below lists competitors of WOOJUNG BIO Inc ranked by their total liabilities.

Company Country Total Liabilities
Filter Vision Public Company Limited
BK:FVC
Thailand ฿1.32 Billion
Slj Global Tbk
JK:SULI
Indonesia Rp486.05 Billion
Kidoz Inc
V:KIDZ
Canada CA$2.19 Million
Nextplat Corp
NASDAQ:NXPL
USA $12.19 Million
Tekom Technologies
TWO:6294
Taiwan NT$891.89 Million
First Graphene Ltd
F:M11
Germany €3.53 Million
Quickfee Ltd
AU:QFE
Australia AU$68.83 Million
Leviathan Gold Ltd
V:LVX
Canada CA$835.69K

Liability Composition Analysis (2016–2025)

This chart breaks down WOOJUNG BIO Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see WOOJUNG BIO Inc (215380) total assets.

Liquidity & Leverage Metrics

WOOJUNG BIO Inc Total Liabilities Ratios Explained

WOOJUNG BIO Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.55 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.89 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.74 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how WOOJUNG BIO Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for WOOJUNG BIO Inc (2016–2025)

The table below shows the annual total liabilities of WOOJUNG BIO Inc from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 ₩63.42 Billion
≈ $42.98 Million
-2.92%
2024-12-31 ₩65.33 Billion
≈ $44.27 Million
-14.45%
2023-12-31 ₩76.36 Billion
≈ $51.75 Million
+16.98%
2022-12-31 ₩65.28 Billion
≈ $44.24 Million
-4.95%
2021-12-31 ₩68.68 Billion
≈ $46.54 Million
+64.36%
2020-12-31 ₩41.78 Billion
≈ $28.32 Million
+34.91%
2019-12-31 ₩30.97 Billion
≈ $20.99 Million
+31.15%
2018-12-31 ₩23.61 Billion
≈ $16.00 Million
+80.62%
2017-12-31 ₩13.07 Billion
≈ $8.86 Million
+812.36%
2016-12-31 ₩1.43 Billion
≈ $971.15K
--

About WOOJUNG BIO Inc

KQ:215380 Korea Biotechnology
Market Cap
$21.84 Million
₩32.22 Billion KRW
Market Cap Rank
#24669 Global
#1778 in Korea
Share Price
₩1933.00
Change (1 day)
-1.02%
52-Week Range
₩1761.00 - ₩3605.00
All Time High
₩13450.00
About

Kolmar BioTech, Inc. engages in the various research services in South Korea. The company provides LAB CLOUD, a bio-specialized accelerator and research platform; and efficacy evaluation, clinical and histopathology, general and inhalation toxicology, behavioral test, bioanalytical, organoids, ADME, NMR analysis, SPR analysis, IND package, shared lab animal facility, breeding lab, microbial and e… Read more